1. Home
  2. ALT vs BFLY Comparison

ALT vs BFLY Comparison

Compare ALT & BFLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • BFLY
  • Stock Information
  • Founded
  • ALT 1997
  • BFLY 2011
  • Country
  • ALT United States
  • BFLY United States
  • Employees
  • ALT N/A
  • BFLY N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • BFLY Medical Electronics
  • Sector
  • ALT Health Care
  • BFLY Health Care
  • Exchange
  • ALT Nasdaq
  • BFLY Nasdaq
  • Market Cap
  • ALT 348.6M
  • BFLY 347.4M
  • IPO Year
  • ALT N/A
  • BFLY N/A
  • Fundamental
  • Price
  • ALT $4.00
  • BFLY $2.15
  • Analyst Decision
  • ALT Strong Buy
  • BFLY Strong Buy
  • Analyst Count
  • ALT 7
  • BFLY 3
  • Target Price
  • ALT $16.50
  • BFLY $3.50
  • AVG Volume (30 Days)
  • ALT 2.7M
  • BFLY 6.2M
  • Earning Date
  • ALT 11-07-2025
  • BFLY 10-31-2025
  • Dividend Yield
  • ALT N/A
  • BFLY N/A
  • EPS Growth
  • ALT N/A
  • BFLY N/A
  • EPS
  • ALT N/A
  • BFLY N/A
  • Revenue
  • ALT $20,000.00
  • BFLY $87,521,000.00
  • Revenue This Year
  • ALT N/A
  • BFLY $13.52
  • Revenue Next Year
  • ALT N/A
  • BFLY $19.47
  • P/E Ratio
  • ALT N/A
  • BFLY N/A
  • Revenue Growth
  • ALT N/A
  • BFLY 23.13
  • 52 Week Low
  • ALT $2.90
  • BFLY $1.32
  • 52 Week High
  • ALT $11.16
  • BFLY $4.98
  • Technical
  • Relative Strength Index (RSI)
  • ALT 52.72
  • BFLY 49.63
  • Support Level
  • ALT $3.83
  • BFLY $2.06
  • Resistance Level
  • ALT $4.15
  • BFLY $2.30
  • Average True Range (ATR)
  • ALT 0.17
  • BFLY 0.16
  • MACD
  • ALT 0.00
  • BFLY -0.04
  • Stochastic Oscillator
  • ALT 58.90
  • BFLY 18.00

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About BFLY Butterfly Network Inc.

Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. The company enables the practical application of ultrasound information in the clinical workflow. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. With its small, handheld size, low cost, and simple user interface.

Share on Social Networks: